Abstract:AIM:To establish a mice model of hepatitis B by using HBV-transgenic mice, and to transfer HBV-specific cytotoxic T lymphocytes (CTL) induced from syngeneic BALB/c mice immunized by a eukaryotic expression vector containing HBV complete genome DNA.METHODS:HBV DNA was obtained from digested pBR322-2HBV and ligated with the vector pcDNA3. Recombinant pcDNA3-HBV was identified by restriction endonuclease assay and transfected into human hepatoma cell line HepG2 with lipofectin. ELISA was used to detect the expression of HBsAg in culture supernatant, and RT-PCR to determine the existence of HBV PreS1 mRNA. BALB/c mice were immunized with pcDNA3-HBV or pcDNA3 by intramuscular injection. ELISA was used to detect the expression of HBsAb in serum. MTT assay was used to measure non-specific or specific proliferation ability and specific killing activity of spleen lymphocytes. Lymphocytes from immunized mice were transferred into HBV-transgenic mice (2.5X10(7) per mouse). Forty-eight hours later, the level of serum protein and transaminase was detected with biochemical method, liver and kidney were sectioned and stained by HE to observe the pathological changes.RESULTS:By enzyme digestion with Eco RI, Xho I and Hind III, the recombinant pcDNA3-HBV was verified to contain a single copy of HBV genome, which was inserted in the positive direction. HepG2 cells transfected with the recombinant could stably express PreS1 mRNA and HBsAg. After immunized by pcDNA3-HBV for 4 weeks, HBsAb was detected in the serum of BALB/c mice. The potential of spleen lymphocytes for both non-specific and specific proliferation and the specific killing activity against target cells were enhanced. The transgenic mice in model group had no significant changes in the level of serum protein but had an obvious increase of ALT and AST. The liver had obvious pathological changes, while the kidney had no evident damage.CONCLUSION:A eukaryotic expression vector pcDNA3-HBV containing HBV complete genome is constructed successfully. HepG2 cells transfected with the recombinant can express PreS1 mRNA and HBsAg stably. Specific cellular immune response can be induced in mice immunized by pcDNA3-HBV. A mice model of acute hepatitis with HBV has been established.

Establishment of Mice Model with Human Viral Hepatitis B

Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome

Establishment and Primary Application of a Mouse Model with Hepatitis B Virus Replication.

An HBV-tolerant immunocompetent model that effectively simulates chronic hepatitis B virus infection in mice.

Establishment of Cell Culture Model and Humanized Mouse Model of Chronic Hepatitis B Virus Infection.

Development of the Mouse Model for Acute Hepatitis B Virus Infection

Establishment of hepatitis B virus infection model in different mice by hydrodynamic injection of pAAV/HBV1.2 plasmid

A New Mouse Model of Acute Hepatitis B Virus Infection

Establishment and Characterization of a Chronic Viral Hepatitis Model Induced by Murine Hepatitis Virus Type 3

Novel hepatitis B virus infection mouse model using herpes simplex virus type 1 thymidine kinase transgenic mice

Establishment of Mouse Model Harboring Hepatitis B Virus X Gene by the Means of Hydrodynamic Injection

Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages

BALB/c Mouse Is a Potential Animal Model System for Studying Acute and Chronic Genotype 4 Hepatitis E Virus Infection.

A Modified Murine Model Based On Hydrodynamic Injection For The Analysis Of Chronic Human Hepatitis B Virus Infection

[Study on the Differences of Two Mouse Models of Hepatitis B Virus Infection by Transduction with Raav8-1. 3HBV].

A Mouse Model for Hbv Immunotolerance and Immunotherapy

Sequential control of hepatitis B virus in a mouse model of acute, self-resolving hepatitis B

Modeling Hepatitis B Virus Infection, Immunopathology and Therapy in Mice

Application of Hepatitis B Virus Replication Mouse Model

[Establishment of Hepatitis B Virus (HBV) Chronic Infection Mouse Model by in Vivo Transduction with a Recombinant Adeno-Associated Virus 8 Carrying 1. 3 Copies of HBV Genome (Raan8-1. 3HBV)].

A spatiotemporally controlled recombinant cccDNA mouse model for studying HBV and developing drugs against the virus